Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neogen (NEOG) EBITDA (2016 - 2026)

Neogen has reported EBITDA over the past 17 years, most recently at -$3.3 million for Q1 2026.

  • For Q1 2026, EBITDA fell 161.11% year-over-year to -$3.3 million; the TTM value through Feb 2026 reached $187.1 million, up 137.54%, while the annual FY2025 figure was -$237.9 million, 7819.47% down from the prior year.
  • EBITDA for Q1 2026 was -$3.3 million at Neogen, up from -$5.4 million in the prior quarter.
  • Over five years, EBITDA peaked at $211.9 million in Q2 2025 and troughed at -$457.5 million in Q4 2024.
  • A 5-year average of -$12.0 million and a median of $6.1 million in 2022 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 3262.7% in 2024 and later surged 535.76% in 2025.
  • Year by year, EBITDA stood at -$7.7 million in 2022, then surged by 288.94% to $14.5 million in 2023, then crashed by 3262.7% to -$457.5 million in 2024, then surged by 98.82% to -$5.4 million in 2025, then surged by 38.63% to -$3.3 million in 2026.
  • Business Quant data shows EBITDA for NEOG at -$3.3 million in Q1 2026, -$5.4 million in Q4 2025, and -$16.1 million in Q3 2025.